VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Stock Comparison
EssilorLuxottica vs Merck & Co., Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
EssilorLuxottica
EL · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into EssilorLuxottica's moat claims, evidence, and risks.
View EL analysisMerck & Co., Inc.
MRK · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Merck & Co., Inc.'s moat claims, evidence, and risks.
View MRK analysisComparison highlights
- Moat score gap: Merck & Co., Inc. leads (71 / 100 vs 69 / 100 for EssilorLuxottica).
- Segment focus: EssilorLuxottica has 2 segments (52.7% in Direct to Consumer); Merck & Co., Inc. has 2 segments (89.5% in Pharmaceutical).
- Moat breadth: EssilorLuxottica has 5 moat types across 3 domains; Merck & Co., Inc. has 5 across 3.
Primary market context
EssilorLuxottica
Direct to Consumer
Optical retail and e-commerce (prescription eyewear and sunglasses)
Global
Consumers (end-users)
Omnichannel retailer + vertically integrated manufacturer/brand owner
52.7%
Merck & Co., Inc.
Pharmaceutical
Branded prescription pharmaceuticals & human vaccines
Global
Wholesalers/retailers, managed care and government payers, hospitals/clinics
R&D-intensive innovator, manufacturer, and marketer
89.5%
Side-by-side metrics
Moat coverage
Shared moat types
EssilorLuxottica strengths
Merck & Co., Inc. strengths
Segment mix
EssilorLuxottica segments
Full profile >Professional Solutions
Oligopoly
Direct to Consumer
Competitive
Merck & Co., Inc. segments
Full profile >Pharmaceutical
Competitive
Animal Health
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.